View Latest Medical and Pharma Bids and Tenders

Open House Drug Discount Agreements Tapentadol In The Non-Sustained Release Dosage Forms, Atc N02Ax06

Open House Drug Discount Agreements Trientin, Atc A16Ax12

Open House Drug Discount Agreements Tapentadol In Non-Sustained Release Dosage Forms, Atc N02Ax06

Open House Drug Discount Agreements Trientin, Atc A16Ax12

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Perindopril And Indapamide (Excluding Perindopril As Arginine Salt), Atc C09Ba54 For The Period 01.02.25 - 31.01.27

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Baricitinib, (Obo) Atc L04Aa37 For The Period 01.02.2025 - 31.01.2027

Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Peg-Epoetin Beta, (Obo) Atc B03Xa03 For The Period 01.02.2025 - 31.01.2027

Open House Drug Discount Agreements Buserelin, Atc L02Ae01

Open House Drug Discount Agreements Tapentadol In Non-Sustained Release Dosage Forms, Atc N02Ax06

Open House Drug Discount Agreements Trientin, Atc A16Ax12